Books > Science & Mathematics > Biology, life sciences > Life sciences: general issues > Neurosciences
|
Buy Now
New Rapid-acting Antidepressants (Hardcover, 1st ed. 2021)
Loot Price: R4,894
Discovery Miles 48 940
|
|
New Rapid-acting Antidepressants (Hardcover, 1st ed. 2021)
Series: Contemporary Clinical Neuroscience
Expected to ship within 12 - 17 working days
|
This book discusses new candidates for rapid-acting
antidepressants, such as (R)-ketamine, (2R,6R)-hydroxynorketamine,
scopolamine, mGluR2/3 antagonists and AMPA receptor agonists. There
are serious limitations to currently available antidepressants,
such as delayed onset and low rates of efficacy. The discovery that
a single dose of ketamine, an NMDAR antagonist, can produce rapid
antidepressant effects that are sustained has led to new research
in this area. In this volume, a variety of novel pharmaceutical
treatments are examined. This volume would be useful to both
researchers and clinicians who work in the field of pharmacology,
specifically CNS drug treatments.
General
Is the information for this product incomplete, wrong or inappropriate?
Let us know about it.
Does this product have an incorrect or missing image?
Send us a new image.
Is this product missing categories?
Add more categories.
Review This Product
No reviews yet - be the first to create one!
|
|
Email address subscribed successfully.
A activation email has been sent to you.
Please click the link in that email to activate your subscription.